Dr. Reeder has 18 years of experience in the biotechnology field, with extensive experience in technology development, target identification and validation, project management and intellectual property. Dr. Reeder previously co-founded Toccata Therapeutics, the first company to develop rapid in vivo drug screening technologies for protein therapeutics. Dr. Reeder received his Ph.D. in molecular biology from Brandeis University.

Dr. Moore has over 22 years of experience in the biotechnology industry, beginning at Genentech, where he ran the mouse knockout and target validation program. He also co-founded Deltagen, which grew to over 400 employees and had a market capitalization of more than $1B at its peak. Dr. Moore received his Ph.D. in molecular biology and immunology from Brandeis University and his A.B. degree in biochemical sciences from Princeton University.